154 related articles for article (PubMed ID: 29650030)
1. Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.
Ullah E; Mall R; Rawi R; Moustaid-Moussa N; Butt AA; Bensmail H
J Transl Med; 2018 Apr; 16(1):99. PubMed ID: 29650030
[TBL] [Abstract][Full Text] [Related]
2. Obesity in Qatar: A Case-Control Study on the Identification of Associated Risk Factors.
Khondaker MTI; Khan JY; Refaee MA; Hajj NE; Rahman MS; Alam T
Diagnostics (Basel); 2020 Oct; 10(11):. PubMed ID: 33138081
[TBL] [Abstract][Full Text] [Related]
3. The Qatar Biobank: background and methods.
Al Kuwari H; Al Thani A; Al Marri A; Al Kaabi A; Abderrahim H; Afifi N; Qafoud F; Chan Q; Tzoulaki I; Downey P; Ward H; Murphy N; Riboli E; Elliott P
BMC Public Health; 2015 Dec; 15():1208. PubMed ID: 26635005
[TBL] [Abstract][Full Text] [Related]
4. Simple risk score to screen for prediabetes: A cross-sectional study from the Qatar Biobank cohort.
Abbas M; Mall R; Errafii K; Lattab A; Ullah E; Bensmail H; Arredouani A
J Diabetes Investig; 2021 Jun; 12(6):988-997. PubMed ID: 33075216
[TBL] [Abstract][Full Text] [Related]
5. Association of low serum magnesium with diabetes and hypertension: Findings from Qatar Biobank study.
Shi Z; Abou-Samra AB
Diabetes Res Clin Pract; 2019 Dec; 158():107903. PubMed ID: 31678625
[TBL] [Abstract][Full Text] [Related]
6. Qatar Biobank Cohort Study: Study Design and First Results.
Al Thani A; Fthenou E; Paparrodopoulos S; Al Marri A; Shi Z; Qafoud F; Afifi N
Am J Epidemiol; 2019 Aug; 188(8):1420-1433. PubMed ID: 30927351
[TBL] [Abstract][Full Text] [Related]
7. Predicting hypertension using machine learning: Findings from Qatar Biobank Study.
AlKaabi LA; Ahmed LS; Al Attiyah MF; Abdel-Rahman ME
PLoS One; 2020; 15(10):e0240370. PubMed ID: 33064740
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar.
Bener A; Zirie M; Janahi IM; Al-Hamaq AO; Musallam M; Wareham NJ
Diabetes Res Clin Pract; 2009 Apr; 84(1):99-106. PubMed ID: 19261345
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Harnessing Qatar Biobank to understand type 2 diabetes and obesity in adult Qataris from the First Qatar Biobank Project.
Ullah E; Mall R; Rawi R; Moustaid-Moussa N; Butt AA; Bensmail H
J Transl Med; 2018 Oct; 16(1):283. PubMed ID: 30322395
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, genetic landscape and classification of childhood diabetes mellitus in the State of Qatar.
Haris B; Saraswathi S; Al-Khawaga S; Hasnah R; Saeed A; Mundekkadan S; Hamed N; Afyouni H; Abdel-Karim T; Mohammed S; Khalifa A; Al-Maadheed M; Al-Zyoud M; Shamekh A; Elawwa A; Al-Khalaf F; Boughorbel S; Petrovski G; Hussain K
J Diabetes Investig; 2021 Dec; 12(12):2141-2148. PubMed ID: 34101350
[TBL] [Abstract][Full Text] [Related]
11. Qatar Biobank: A Paradigm of Translating Biobank Science into Evidence-Based Health Care Interventions.
Fthenou E; Al Thani A; Al Marri A; Afifi N
Biopreserv Biobank; 2019 Dec; 17(6):491-493. PubMed ID: 31833811
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and determinants of metabolic syndrome in Qatar: results from a National Health Survey.
Al-Thani MH; Al-Thani AA; Cheema S; Sheikh J; Mamtani R; Lowenfels AB; Al-Chetachi WF; Almalki BA; Hassan Khalifa SA; Haj Bakri AO; Maisonneuve P
BMJ Open; 2016 Sep; 6(9):e009514. PubMed ID: 27601485
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic associations of type 2 diabetes and BMI in an Arab population.
Al Muftah WA; Al-Shafai M; Zaghlool SB; Visconti A; Tsai PC; Kumar P; Spector T; Bell J; Falchi M; Suhre K
Clin Epigenetics; 2016; 8():13. PubMed ID: 26823690
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary artery diseases.
Daghash MH; Bener A; Zirie M; Dabdoob W; Al-Hamaq AO; Al-Arabi ZA
Int J Cardiol; 2007 Sep; 121(1):91-2. PubMed ID: 17291606
[TBL] [Abstract][Full Text] [Related]
15. Prevention of type II diabetes mellitus in Qatar: Who is at risk?
Christos PJ; Chemaitelly H; Abu-Raddad LJ; Ali Zirie M; Deleu D; Mushlin AI
Qatar Med J; 2014; 2014(2):70-81. PubMed ID: 25745596
[TBL] [Abstract][Full Text] [Related]
16. Genetics, obesity, and environmental risk factors associated with type 2 diabetes.
Bener A; Zirie M; Al-Rikabi A
Croat Med J; 2005 Apr; 46(2):302-7. PubMed ID: 15849854
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes epidemic and key risk factors in Qatar: a mathematical modeling analysis.
Awad SF; A Toumi A; A Al-Mutawaa K; A Alyafei S; A Ijaz M; A H Khalifa S; B Kokku S; C M Mishra A; V Poovelil B; B Soussi M; G El-Nahas K; O Al-Hamaq A; A Critchley J; H Al-Thani M; Abu-Raddad LJ
BMJ Open Diabetes Res Care; 2022 Apr; 10(2):. PubMed ID: 35443971
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and Metabo-Clinical Signatures of Type 2 Diabetes, Obesity, Retinopathy, and Dyslipidemia.
Yousri NA; Suhre K; Yassin E; Al-Shakaki A; Robay A; Elshafei M; Chidiac O; Hunt SC; Crystal RG; Fakhro KA
Diabetes; 2022 Feb; 71(2):184-205. PubMed ID: 34732537
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and characteristics of overweight and obesity among students in Qatar.
Al-Thani M; Al-Thani A; Alyafei S; Al-Chetachi W; Khalifa SE; Ahmed A; Ahmad A; Vinodson B; Akram H
Public Health; 2018 Jul; 160():143-149. PubMed ID: 29704956
[TBL] [Abstract][Full Text] [Related]
20. Forecasting the burden of type 2 diabetes mellitus in Qatar to 2050: A novel modeling approach.
Awad SF; O'Flaherty M; Critchley J; Abu-Raddad LJ
Diabetes Res Clin Pract; 2018 Mar; 137():100-108. PubMed ID: 29175341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
